POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING

Clinical trials for POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING explained in plain language.

Never miss a new study

Get alerted when new POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING trials appear

Sign up with your email to follow new studies for POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug trial aims to control debilitating nerve disease

Disease control Recruiting now

This study is testing whether a drug called nipocalimab can help control chronic inflammatory demyelinating polyneuropathy (CIDP), a condition that causes progressive weakness and disability. The trial will enroll about 201 adults with CIDP to see if nipocalimab can delay the ret…

Matched conditions: POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING

Phase: PHASE2, PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING

Get alerted when new POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING trials appear

New drug trial aims to control debilitating nerve disease